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Summary This report describes a population-based case-control study that aimed to assess and quantify the risk of children with congenital
malformations developing cancer. Three sources of data were used: the Victorian Cancer Register, the Victorian Perinatal Data Register
(VPDR) and the Victorian Congenital Malformations/Birth Defects Register. Cases included all Victorian children bom between 1984 and
1993 who developed cancer. Four controls per case, matched on birth date, were randomly selected from the VPDR. Record linkage between
registers provided malformation data. A matched case-control analysis was undertaken. Of the 632 cancer cases, 570 (90.2%) were linked
to the VPDR. The congenital malformation prevalence in children with cancer was 9.6% compared with 2.5% in the controls [odds ratio (OR)
4.5, 95% Cl 3.1-6.7]. A strong association was found with chromosomal defects (OR=16.7, 95% Cl 6.1-45.3), in particular Down's syndrome
(OR=27.1, 95% Cl 6.0-122). Most other birth defect groups were also associated with increased cancer risk. The increased risk of leukaemia
in children with Down's syndrome was confirmed, and children with central nervous system (CNS) defects were found to be at increased risk
of CNS tumours. The report confirms that children with congenital malformations have increased risks of various malignancies. These
findings may provide clues to the underlying aetiology of childhood cancer, as congenital malformations are felt to be a marker of exposures
or processes which may increase cancer risk. The usefulness of record linkage between accurate population-based registers in the
epidemiological study of disease has also been reinforced.
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Associations have been reported between congenital malforma-
tions and cancer in childhood. and it is considered that these condi-
tions may be at the end of a common aetiological. in particular
genetic. pathway. Through the study of such associations. the
determination of underlying genetic changes involved in cancer
may be possible (Narod et al. 1997). In addition. such knowledge
of cancer risk in children with congenital malformations may lead
to strategies for early detection ofmalignancy.
Victoria has three well-established. population-based registers
collecting information on cancer. perinatal factors and birth
defects in children. and covers a defined population with approxi-
mately 64 000 births annually. This unusual situation provided an
opportunity to link the registers and assess any association
between congenital malformations and childhood cancer.
PATIENTS AND METHODS
Data sources
The Victorian Cancer Recister (VCR) was established in 1940 bs
the Anti-Cancer Council ofVictoria. and in 1981 legislation made
notification of cancer mandatorv for all Victorian hospitals and
pathology laboratories. The VCR follows internationally agreed
procedures for the collection and processing of cancer incidence
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data. For the Victorian population. of around 4.5 million, approxi-
mately 15 000 new cancers are notified each vear. includinc about
130 in children under the age of 15 years (Giles et al. 1995). The
registrv includes all children resident in Victoria at the time of
cancer diagnosis.
The ConsultatiN-e Council on Obstetric and Paediatric Mortality
and Morbidityv is a state government-leaislated surneillance
svstem. under which information is collected on all births in
Victoria by the Victorian Penrnatal Data Collection Unit (VPDCU)
within the Department of Human Services. In Victoria. in 1994.
64376 live births were notified to the Regyister (The Consultative
Council on Obstetric and Paediatric Mortality and Morbiditv.
1996). representingy 99.6% ofall births (Rilev and Griffin. 1997).
The VPDCU also maintains a state-svide surneillance system
for congenital malformations or birth defects - the Congenital
Malformations/Birth Defects Register (CMR). The register was
established in 1984. for children born since 1 Januarn 1982 in
the state of Victoria. and records are linked to the VPDR.
Notifications come from many sources. are activelv x-erified and
then coded using the British Paediatric Association modification
of ICD-9 (British Paediatric Association. 1979). ActiN-e updating
ofrecords occurs so that information on acongenital malformation
that is recognized at any age. up to 15 years. is always included in
the register in the y ear of the child's birth. The regyister collects
information on both structural defects and chromosomal abnor-
malities present at birth. It also obtains data on children with
internal errors in metabolism. haematological disorders. conaen-
ital infections, conaenital neoplasms and developmental delay.
providincg the condition was present at birth. The register excludes
certain trivial malformations. such as birth marks. skin tags and
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Table 1 The risk of childhood cancer in children with any. and specific. congenital malformations
Codes Congenital malformatontype Cases Controls Crude OF P-value Adjusted ORb P-value
(ICD-9) n (%) n (%) (95% Cl) (95% Cl)
n570 rw2m8
Any congenital maltformation 55 (9.6) 58 (2.5) 4.1 (2.8-6.0) <0.001 4.5 (3.1-6.7) <0.001
Number of malformations
None 515 (90.4) 2222 (97.5) 1.0 1.0 - -
One 40 (7.0) 46 (2.0) 3.7 (2.4-5.8) <0.001 4.0 (2.6-6.2) <0.001
Two or more 15 (2.6) 12 (0.5) 5.4 (2.5-11.6) <0.001 7.2 (3.2-16.3) <0.001
758 Chromosmal 18 5 14.7 (5.4-39.7) <0.001 16.7 (6.1-45.3) <0.001
758.00-09 Down's syndrome 12 2 24.3 (5.4-109) <0.001 27.1 (6.0-122) <0.001
Wihout Down's syndrome 6 3 8.1 (2.0-32.5) 0.003 9.2 (2.3-37.3) 0.002
740-742. 340-2, Nervous system 5 3 7.0(1.6-28.1) 0.009 6.5 (1.5-27.8) 0.01
344. 350-9
745 Cardiac septal/bulbous cordis 8 4 8.1 (2.4-27.1) <0.001 8.6 (2.6-29.0) <0.001
745.40-49 VSD 3 3 4.0 (0.8-19.9) 0.09 4.4 (0.9-22.3) 0.07
Wiut Down's syndrome 4 4 4.0 (1.0-16.1) 0.05 4.1 (1.0-16.8) 0.05
746-747 Other heart/circulatory system 9 7 5.2 (1.9-14.1) 0.001 5.5 (2.0-15.0) <0.001
Wthout Down's syndrome 6 7 3.5 (1.2-10.3) 0.03 3.6 (1.2-10.8) 0.02
748 Respiratory system 3 1 12.0 (1.3-115) 0.03 14.5 (1.5-142) 0.02
743. 744 Eye/face/neck malformation 5 3 6.7 (1.6-28.1) 0.009 7.3 (1.7-30.9) 0.007
750. 751 Gastrointestinal system 7 11 2.6 (0.99-6.6) 0.053 3.3 (1.2-9.0) 0.02
754-756 Musculoskeletal 13 22 2.4 (1.2-4.8) 0.01 2.7 (1.3-5.4) 0.007
754.30 Congenital dislocation hip 4 5 3.2 (0.9-12.0) 0.08 3.2 (0.9-12.5) 0.07
752-753 Genito-urinary system 6 9 2.7 (0.95-7.6) 0.06 2.9 (1.0-8.1) 0.05
752.60 Hypospadias 3 5 2.4 (0.6-10.1) 0.23 2.6 (0.6-10.9) 0.19
240-279 Endocrine/metabolic 2 1 8.0 (0.7-88.2) 0.09 8.4 (0.8-93.2) 0.08
749 Cleft lip and/or palate 2 2 4.0 (0.6-28.4) 0.17 9.0 (0.8-100) 0.07
aCrude OR controlling for matching vanable (6-month calendar period of birth). "Adjusted OR controlling for 6-month calendar penod. gender. birth weight,
gestational age at birth and matemal age at birth.
hydroceles. The birth prevalence for congenital malformations in
Victoria is 3.1%c (Riley and Halliday. 1996).
Case selection
Cases selected from the VCR consisted of all children diagnosed
with cancer who were born during the 10-year period from 1
January 1984 to 31 December 1993. This period was selected to
correspond with that covered by the CMR. Case selection from the
VCR occurred at the end of 1995. At this time. 1994 and 1995
cancer notification data were not available for inclusion. After
exclusion of 14 cases with benign tumours or cancers of uncertain
behaviour, and five cases born interstate. there were 632 cases
eligible for linkage.
Control selection
Four controls were randomly selected from all Victorian births
present on the VPDR and matched to each case on date of birth
(within 6 months). excluding stillbirths. neonatal deaths and twin
of a cancer case. Matching used birth date to allow for changes in
reporting patterns to the CMR over its 10 years ofdata collection.
Cases and controls thus had an equal likelihood of being reported
to the CMR should thev have a birth defect.
Record linkage
Linkage of cancer cases to the VPDR was undertaken manuallv
usin, child's surname. data of birth. gender. and occasionally post-
code of residence. Linkage was assumed if all variables matched
perfectly. Linked cases and selected controls were then linked
directly to the CMR using the perinatal registration number. All
malignancies reported to the CMR were excluded from the malfor-
mation data. Children residing in Victoria but born outside the
state could not be linked to the VPDR.
Statistical methods
Matched case-control analysis was undertaken in EGRET
(Statistics and Epidemiology Research Corporation. 1991). Crude
odds ratios for comparisons of categorical data were calculated
using conditional logistic regression adjusting for the matching
variable (6-month calendar periods ofbirth), but no other variable.
A Mantel-Haenszel test was used to assess linear trend ofgrouped
continuous variables.
Multivariate analysis also used conditional logistic regression.
All odds ratios are adjusted for gender. birth weight. maternal age
at birth and gestational age at birth. The exceptions to this are the
subanalyses of the association between cancer morphology types
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Table 2 The risk of specific childhood cancers in children with any congenital malformaabn
Malignant cancer n a n (%) with Crude ORb P-value Adjusted OW P-value
cases malformatnna (95% Cl) (95% Cl)
Major morphology groups
Leukaemia 224 19 (8.5) 3.5 (2.0-5.9) <0.001 3.7 (2.2-6.5) <0.001
Central nervous system 92 9 (9.7) 4.2 (2.0-8.7) <0.001 4.7 (2.2-10.0) <0.001
Sympathetic nervous system 56 7 (12.5) 6.1 (2.6-14.3) <0.001 7.2 (3.0-17.1) <0.001
Lymphoma 45 2 (4.4) 1.9 (0.4-8.1) 0.39 2.1 (0.5-9.2) 0.31
Soft-tissue sarcoma 43 3(7.0) 3.1 (0.9-10.5) 0.07 3.5 (1.0-11.8) 0.05
Renal 42 4 (9.5) 3.9 (1.3-11.4) 0.01 4.6 (1.6-13.8) 0.006
Retinoblastoma 26 5 (19.2) 10.7 (3.8-30.3) <0.001 15.0 (5.1-44.2) <0.001
Germ cell. gonadal 21 4 (19.0) 8.4 (2.7-26.7) <0.001 8.9 (2.6-30.3) <0.001
Bone 8 2 (25.0) 12.6 (2.3-8.1) 0.003 23.2 (3.8-143) <0.001
Hepatic 7 1 (14.3) 6.5 (0.7-58.0) 0.09 9.3 (0.9-94.2) 0.06
Carcinoma, malignant epithelial 7 0 - - - -
Other malignancy 2 0 - - - -
Major cancer types
Acute lymphocybc leukaemia 185 9 (4.9) 1.9 (0.9-3.8) 0.10 2.0 (0.96-4.1) 0.07
Acute non-lymphocybc leukaemia 32 7 (21.9) 11.1 (4.5-27.6) <0.001 11.6 (4.6-29.4) <0.001
Neuroblastoma 52 7 (13.5) 6.7 (2.8-15.7) <0.001 7.9 (3.3-18.8) <0.001
Wilm's tumour 40 4 (10.0) 4.1 (1.4-12.0) 0.01 4.9 (1.6-14.5) 0.005
Astrocytoma 39 3 (7.7) 3.1 (0.9-10.4) 0.07 3.5 (0.98-12.5) 0.054
Rhabdomyosarcoma 23 3 (13.0) 7.7 (2.2-27.7) 0.002 7.9 (2.2-28.8) 0.002
aNumber children with cancer = 570, number of cancers = 573. "Crude OR controlling for matching variable (6-month calendar period of birth). cAdjusted OR
controlling for 6-month calendar period, gender, birth weight, gestational age at birth and maternal age at birth.
and specific congenital malformations in which. because of small
numbers ofchildren. only crude odds ratios arepresented. All odds
ratios are presented with their 95% confidence interval following
in parentheses. Statistical significance was taken at the 0.05 level.
Given the study design and a 2.5% prevalence of major malfor-
mations in the control population. the study had a powerof80% to
detect an odds ratio of 2.05 (Epi Info 6. 1994).
Cancers cases were grouped according to the Intemational
Classification Scheme for Childhood Cancer (Parkin et al. 1988).
Malformations were recoded into: malformations which occur
frequently (e.g. Down's syndrome). anatomical systems (e.g.
nervous) and certain groups. e.g. cardiac septal and bulbus cordis
(this group ofcardiac malformations includes septal defects. endo-
cardial cushion defects. common truncus. transposition great
arteries and tetralogy of Fallot). Chromosomal. cardiac septal
defects and other cardiovascular system defects were also coded
separately. excluding children with Dow-n's syndrome.
Ethical approval was granted by the Consultative Council on
Obstetnc and PaediatncMortality and Morbidity andthe Anti-Cancer
Council ofVictonra Data confidentiality was strictly maintained. and
once records were linked all identifying information was removed
RESULTS
Of the 632 children with cancer. 570 (90.2%) were successfully
linked to the Perinatal Register. For these cases. 2280 controls
were selected. There was no significant difference found between
the linked and the 62 unlinked cases. with respect to type of
tumour. gender or birth date distribution. Three children had two
cancers each. giv'ing a total of 573 cancers. These were composed
of leukaemias 39.1% (mainly acute lymphocytic leukaemia.
27.6%). central nervous system tumours (16.1%) and sympathetic
nervous system tumours (9.8%). The distribution was biased
towards tumours that occurred at younger ages as the maximum
age of a case was 10 years.
Fifty-five (9.6%7c) of the 570 children with cancer had a congen-
ital malformation compared with 2.5%c of the control children. a
highly significant odds ratio (OR) of 4.5 (95%7c CI 3.1-6.7). The
risk of cancer increased with increasing number of malformations
(Table 1). Children with chromosomal defects had the highest risk
of cancer (OR = 16.7. 95%7c CI 6.1-45.3). Part of this consisted of
children with trisomy 21. or Down's syndrome. who had a 27-fold
risk of cancer (95%7c CI 6.0-122). Children with other chromo-
somal defects also had an increased cancernrsk (OR = 9.2. 95%eCI
2.3-37.3). Risk of cancer was increased in children with nervous
system defects (OR = 6.5. 95% CI 1.5-27.8). While cardiac septal
closure defects were highly associated with cancer. when the cases
with Down's syndrome were removed this association reduced.
Congenital malformations found to be significantly associated
with cancer were respiratory system defects. and eye. face and
neck malformnations. and gastrointestinal system defects (Table 1).
There were few children with endocnrne and metabolic defects or
cleft lip and palate. and these malformations had a non-significant
increased cancer risk. The increased risk with genitourinary
system defects was ofborderline statistical significance.
Most of the major childhood cancer norphology groups were
significantly associated with malformations (Table 2). The association
between malformations and leukaemia (OR = 3.7. 95% CI 2.2-6.5)
was mainly due to the high risk ofacute non-lymphocytic leukaemia
(ANLL). because acute lymphocytic leukaemia (ALL) had a lower.
non-significant risk. Children with malformations were at nrsk of
central nervous system (CNS) tumours (OR = 4.7.95%7c CI2.2-10.0).
though the mainCNS malignancy. astrocytoma. had only aborderline
association. Non-significantly raised odds ratios were found for
lvmphomas and hepatic tumours.
Multivariate analysisadjusting for gender. birth weight. gestational
age at birth and maternal age at birth resulted in little change in the
nsks of cancer. indicating minimal confounding. The small numbers
of cases and children with malformations, however, resulted in an
appreciable odds ratio change in relation tobone tumours (Table 2).
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Trisoms 21. or Down's svndrome. was highly! associated wmith
leukaemia (OR = 64.2. 95%7c CI 13.8-441). and the risk w%as greater
for developing ANLL than ALL. Children with ner ous system or
face/eye/neck defects were at increased risk of CNS tumours.
Chromosomal anomalies significantly increased the risk of
retinoblastoma and Wilm's tumour. and genitourinary defects
increased the risk ofrhabdomyosarcoma (Table 3).
DISCUSSION
This study confirms and quantifies associations between congen-
ital malformations and childhood cancer. Its strengths result from
the provision of accurate and complete case data from the VCR:
the population-based design. ensuring a control group selected
without bias: and the CMR providing complete and accurate ascer-
tainment of major malformations. In contrast. its power is limited
by the size ofthe Victorian population. and the rarity ofboth child-
hood cancer and congenital malformations. The small numbers.
particularly in cancer or malformation subgroups. make the preci-
sion of certain estimates poor. as reflected by wide confidence
intervals. In addition. the many statistical tests that were carried
out could have led to tyvpe one errors.
Several other aspects of the study deserve notice. namely a
potential bias in ascertainment of malformation information.
control population selection. the malformation prevalence in the
control children and the loss ofcases in the record linkage process.
Because notification of malformations is voluntary. ascertain-
ment may be incomplete for both cases and controls. Such non-
differential errors in exposure ascertainment would not greatly
alter the odds ratios or. if they did. they ma) result in a bias
towards lack of association (Wacholder et al. 1992). It is possible
that the relative ill-health ofchildren with cancer promotes recog-
nition and notification of malformations. To assess potential bias
in malformation data ascertainment. the cancerdiagnosis date was
compared with the malformation notification date. For eight
(14.5%c) of the 55 cases. the notification may not have occurred
before. and may consequently not be independent of. the cancer
diagnosis (although three of these children had perinatal
neoplasms). When these cases are removed. the estimate of
malformation prevalence in children with cancer remains high at
8.4%7. As the majority of children with cancer and malformations
had their malformation notified well in advance of their cancer
diagnosis. it is assumed that biased malformation data ascertain-
ment did not play a major role in this study.
One problem with the control population was that it was only
known whether they had survived to 29 days and not to the equiv-
alent age ofdiagnosis ofcancer in the corresponding case. While it
is acknowledged that there mav be differential mortalitv (from
causes other than cancer) in children w-ith congenital malforma-
tions compared with those without. death in childhood is a rare
occurrence and any potential bias would be small. In addition. we
believe that our existing, process involving multiple sources of
notification of congenital malformations would ensure reporting
ofa potentially lethal malformation within the first 28 days oflife.
The control children's birth defect prevalence rate (2.5%) is
considered to be an accurate estimation ofthe prevalence ofmajor
malformations in the general population (Eurocat Working Group.
1995). The higher prevalence in certain previous reports may be
due to our exclusion of stillbirths and neonatal deaths from the
control population. and also to possible differences in true preva-
lence. ascertainment and birth defect definitions.
As record linkage was not based on a unique identifier. the loss
of 9.8% of the cancer cases is not considered to be excessive. and
the comparison of linked and unlinked cases revealed no signifi-
cant differences. Because linkage assumed that child and mother
held the same sumame. failure to link records may have been due
to surname differences. a name change since birth. or. more
probably. the case child being born outside Victoria.
We found a fourfold risk of cancer in children with malforma-
tions. The overall malformation prevalence of9.6%- is greater than
the 7.7% and the 5.5% reported in two US register-based studies
(Mili et al. 1993a and b). and the 4.9%7 reported in children on a
Table 3 Summary of s.gntficant associations between childhood cancer morphology groups and specific congenital matformations
Cancer group - specific malformatIon Cases Controls Crude OF P-value
n n (95%CI)
Leukaemia - Downs syndrome 12 2 64.2 (3.8-442) <0.001
ALL - Down's syndrome 4 2 23.9 (3.7-196) <0.001
ANLL - all chromosomal 6 5 105 (25.7-431) <0.001
ANLL- Down's syndrome 5 2 F, <0.001
ANLL - non-Down's chromosomial 1 3 20.3 (1.8-224) 0.01
CNS tumour- nervous system 4 3 27.8 (6.1-127) <0.001
CNS tumour - eye/face/neck 2 3 16.8 (2.7-103) 0.002
Retinoblastoma - all chromosomal 2 5 54.8 (7.7-391) <0.001
Neuroblastoma - eye/face/neck 2 3 26.6 (4.3-166) <0.001
Neuroblastoma - gastrointestinal system 2 11 9.3 (1.9-46.1) 0.007
Neuroblastoma - nervous system 1 3 18.3 (1.8-184) 0.01
Wilms' tumour - eye/face/neck 1 3 18.9 (1.9-190) 0.01
Wilms' tumour- all chromosomal 1 5 15.7 (1.7-153) 0.02
Bone tumour - all chromosomal 1 5 28.6 (2.9-280) 0.004
Rhabdomyosarcoma - genitourinary system 1 9 18.2 (2.1-157) 0.008
aCrude OR controlling forthe matching variable. 6Calculation not possible.
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British cancer register (Narod et al. 1997). However, it appears
comparable to a case-control study in the UK that reported a
malformation prevalence of 10.8% (Mann et al. 1993). although
this study included many trivial defects. which have been excluded
from our study. These differences could be due to the previously
discussed bias in malformation ascertainment, but probably reflect
higher ascertainment ofcongenital malformations by the Victorian
register.
The study confirmed the high risk of children with Down's
syndrome developing cancer. The 64-fold risk of leukaemia in
children with Down's syndrome is higher than previously reported
in a review on the subject (Fong. 1987) and in Swedish registry-
based study (Zack et al. 1991 ). This may be due to differing ascer-
tainment methodologies in the early studies on which the review is
based. orthat the Swedish study relied on congenital malformation
reporting solely from the birth form. The risks of ALL and ANLL
were. however, found to be similar to those reported in two other
reports (Cnattingius et al. 1995a and b). Bias due to underre-
porting of Down's syndrome seems unlikely as the ascertainment
of chromosomal abnormalities by the register was found to be
100%7 in a recent validation study (Kilkenny et al. 1995).
Each year in Victoria there are about 75 children born (not
including terminations ofpregnancy) with Down's syndrome. and
over the 10-year study period there were 12 children with Down's
syndrome who developed leukaemia (approximately one in 60
children with Down's syndrome up to age 10).
Some recognized cancer-congential malformation associations
have been quantified. namely Down's syndrome and leukaemia.
retinoblastoma and chromosomal defects. and Wilm's tumour and
chromosomal defects. New associations include those found
between central nervous system tumours and nervous system
defects and eye/face/neck defects. and those between neuro-
blastoma and the same malformation groups.
These associations have a basic anatomical similarity. and this
may point towards common embryological influences. There is
also evidence that germline genetic defects lead to malformations.
and either directly lead to the cancer or cause a predisposition
to cancer development. Such defects have been found in
subgroups of both Wilm's tumours (Riccardi et al. 1978: Haber.
1992: Coppes et al. 1993) and retinoblastomas (Knudson. 1971:
Cowell. 1994). and more recently with Cowden disease and
a aermline mutation in the tumour suppressor gene PTEN (Marsh
et al. 1998).
The high. and statistically significant. odds ratios found in this
study provide strong evidence of links between the presence of
congenital malformations and the development ofcancer in child-
hood. Many 'cancer-prone' congenital malformation syndromes
have been described. for example. those associated with immune
disorders. overgrowth syndromes. multiple hamartomas and
chromosomal abnormalities (POSSUM. 1995). Such congerntal
malformations may be markers of other exposures or processes
that increase the risk of childhood cancer. The identification
of cancer-prone syndromes. confir'med with epidemiological
evidence, should spur increased efforts to understand the under-
lying links. which may lead to the localization and function of
gene mutations involved in cancer development (Narod et al.
1997).
Apart from adding to the small pool ofknowledtge on childhood
cancer aetiolog>y. our findingrs have emphasized the usefulness of
accurate population-based registers in the elucidation of disease
risk factors.
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